Post-approval studies (Phase 4)Study completedNCT06252051
What this trial is testing
Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD)
Who this might be right for
InfluenzaVaccine ReactionDiabetes Mellitus+1 more
Universitas Padjadjaran 76